跳至主要内容
临床试验/CTRI/2013/04/003566
CTRI/2013/04/003566招募中未知

Vitamin D supplementation to improve immune responses to vaccines administered in early infancy â?? The Nutrivac-D trial

Department of Biotechnology0 个研究点目标入组 900 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
900

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnant women will be checked for inclusion criteria during pregnancy & labour, after birth when breastfeeding is established within the first 24 hours.
  • Inclusion criteria during pregnancy and labour are:
  • 1. Pregnant at any gestation when screened antenatally; Pregnancy full term ( > 37 and < 41 completed weeks) when screened again at labour (consent will only be taken in the antenatal period and not during labour)
  • 2. Will stay in study area for a period of at least 6 months after delivery
  • 3. Delivery by vaginal route or by elective cesarian section
  • Inclusion criteria at birth and within 24 hours:
  • 1. Single term newborn (gestational age > 37 and < 41 weeks at birth) < 24 hours old.
  • 2. Born by normal vaginal route or elective caesarean section.
  • 3. Will stay in study area for a period of atleast 6 months after delivery
  • 4. Breastfeeding established.

排除标准

  • Exclusion criteria during pregnancy and intrapartum period.
  • 1. A mother with a history of > 5 pregnancies.
  • 2. Multiple gestation.
  • 3. Presence of any documented major maternal medical or surgical illness e.g. HIV, Hepatitis B, Tuberculosis, TORCH infections, syphilis, malignancy or immunodeficiency, etc.
  • 4. Presence of fetal (major) congenital anomalies diagnosed in utero.
  • 5. Any infection during pregnancy that required hospitalization.
  • 6. Blood transfusion during pregnancy.
  • 7. History of maternal eclampsia / preeclampsia / hypertension with significant proteinuria ( > 3+) during pregnancy.
  • Exclusion criteria at birth and within 24 hrs:
  • 1. One minute Apgar of < 7/10.
  • 2. Birth weight < 1.8 kg.
  • 3. Multiple gestation.
  • 4. Major congenital anomalies diagnosed prior to birth or during a clinical examination by a
  • pediatrician performed within the first 24 hours.
  • 5. Newborn required admission to neonatal intensive care prior to randomization.
  • 6. Informed written consent not provided by parents.

研究者

发起方
Department of Biotechnology

相似试验

进行中(未招募)
1 期
Hepatitis immunisation and vitamin D supplementatioThe effect of vitamin D supplementation on immune response following hepatitis B vaccine in incident and prevalent hemodialysis patients with vitamin D deficiencyMedDRA version: 14.1Level: LLTClassification code 10054181Term: Hepatitis B immunizationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: LLTClassification code 10019480Term: HemodialysisSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10047626Term: Vitamin D deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disorders
EUCTR2011-004621-26-ATMedical University Graz
尚未招募
3 期
Effect of Vitamin D supplementation on immune response following COVID vaccine
CTRI/2021/08/035709SEHEAC New Delhi
终止
不适用
Changes to the immune system after vitamin D supplementation in healthy individuals and people with multiple sclerosisNeurological - Multiple sclerosisMultiple sclerosis
ACTRN12621000597897Alfred Hospital3
进行中(未招募)
1 期
An initial, short-duration study of vitamin D versus an inactive therapy on the ability of the human immune system to counteract the effects of Multiple Sclerosis on the brain and the effects of vitamin D on the immune system in healthy individuals.MedDRA version: 14.1Level: HLTClassification code 10052785Term: Multiple sclerosis acute and progressiveSystem Organ Class: 10029205 - Nervous system disordersMultiple Sclerosis
EUCTR2012-000635-68-IEniversity College Dublin
已完成
不适用
Effects of Vitamin D Supplementation on Immune Function in InfantsVitamin D Deficiency
NCT04461665Shih Chien University59